ClinicalTrials.Veeva

Menu

Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep

Johns Hopkins University logo

Johns Hopkins University

Status

Withdrawn

Conditions

Healthy Adults

Treatments

Device: Nasal High Flow

Study type

Interventional

Funder types

Other

Identifiers

NCT02547688
IRB00046727

Details and patient eligibility

About

Preliminary data show that high flow nasal air has been shown to reduce promote heat exchange due to evaporation of nasal mucus by the air flow resulting in heat loss. It is unclear whether unidirectional nasal airflow is well tolerated in healthy individuals. The central hypothesis of this proposal is that dry high flow nasal air will be sufficiently tolerated in healthy adults.

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy men and women
  • Able to consent
  • Age ≥ 18
  • BMI<30kg/m2

Exclusion criteria

  • Previous diagnosis of obstructive sleep apnea or sleep disorder
  • History of Constant Positive Airway Pressure treatment for Obstructive Sleep Apnea
  • History of recurrent epistasis
  • Pregnancy (self-report)
  • Deviated nasal septum
  • Unstable cardiovascular disease (decompensated Congestive Heart Failure, myocardial infarction or revascularization procedures, unstable arrhythmias)
  • Uncontrolled hypertension with BP > 190/110
  • Daytime hypoxemia with oxygen saturation<90% (measured at history and physical examination)
  • Supplemental oxygen use
  • Work in transportation industry as a driver or pilot.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Nasal High Flow
Other group
Description:
All subjects are in this group
Treatment:
Device: Nasal High Flow

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems